Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;35(6):3432-3441.
doi: 10.1007/s00330-024-11188-3. Epub 2024 Dec 5.

ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics

Affiliations
Review

ESR Essentials: how to get to valuable radiology AI: the role of early health technology assessment-practice recommendations by the European Society of Medical Imaging Informatics

Erik H M Kemper et al. Eur Radiol. 2025 Jun.

Abstract

AI tools in radiology are revolutionising the diagnosis, evaluation, and management of patients. However, there is a major gap between the large number of developed AI tools and those translated into daily clinical practice, which can be primarily attributed to limited usefulness and trust in current AI tools. Instead of technically driven development, little effort has been put into value-based development to ensure AI tools will have a clinically relevant impact on patient care. An iterative comprehensive value evaluation process covering the complete AI tool lifecycle should be part of radiology AI development. For value assessment of health technologies, health technology assessment (HTA) is an extensively used and comprehensive method. While most aspects of value covered by HTA apply to radiology AI, additional aspects, including transparency, explainability, and robustness, are unique to radiology AI and crucial in its value assessment. Additionally, value assessment should already be included early in the design stage to determine the potential impact and subsequent requirements of the AI tool. Such early assessment should be systematic, transparent, and practical to ensure all stakeholders and value aspects are considered. Hence, early value-based development by incorporating early HTA will lead to more valuable AI tools and thus facilitate translation to clinical practice. CLINICAL RELEVANCE STATEMENT: This paper advocates for the use of early value-based assessments. These assessments promote a comprehensive evaluation on how an AI tool in development can provide value in clinical practice and thus help improve the quality of these tools and the clinical process they support. KEY POINTS: Value in radiology AI should be perceived as a comprehensive term including health technology assessment domains and AI-specific domains. Incorporation of an early health technology assessment for radiology AI during development will lead to more valuable radiology AI tools. Comprehensive and transparent value assessment of radiology AI tools is essential for their widespread adoption.

Keywords: Artificial intelligence; Radiology; Stakeholder participation; Technology assessment (Biomedical); Value-based healthcare.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Jacob J. Visser. Conflict of interest: M.H. is speakers honoraria from industry; support for attending meetings and/or travel from scientific societies; EuSoMII Board member, ESR eHealth & Informatics Subcommittee member, ECR Imaging Informatics/Artificial Intelligence and Machine Learning Chairperson 2025, committee member with FMS (Dutch), and Radiology: Artificial Intelligence associate editor and trainee editorial board advisory panel (all unpaid). M.E.K. is a Scientific Editorial Board member of European Radiology and has not taken part in the review and decision process of this paper. J.J.V.: Grant to the institution from Qure.ai/Enlitic; consulting fees from Tegus; payment to an institution for lectures from Roche; travel grant from Qure.ai; participation on advisory board from Contextflow, Noaber Foundation, and NLC Ventures; leadership role on the steering committee of the PINPOINT Project (payment to institution from AstraZeneca) and RSNA Common Data Elements Steering Committee (unpaid); chair scientific committee EuSoMII (unpaid); chair ESR value-based radiology subcommittee (unpaid); phantom shares in Contextflow and Quibim; member editorial Board European Journal of Radiology (unpaid). The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary. Informed consent: Written informed consent was not required. Ethical approval: Institutional Review Board approval was not required. Study subjects or cohorts overlap: Not applicable. Methodology: Practice recommendations

Figures

Fig. 1
Fig. 1
Simplified overview of the radiology AI development. Four stages as distinguished by IJzerman et al [40]: Basic Research, Translational Research, Clinical Research, and Access and Pricing. Valuable AI in radiology can be determined by comprehensive value assessment such as the Health Technology Assessment (HTA) Core Model®. Guidance during the development process to achieve value and cover the development gap can be performed by an early Health Technology Assessment (eHTA) framework visualised here as an iterative process of HTA domain assessment and two eHTA methods (e.g. decision modelling and multiple criteria decision analysis). AI, artificial intelligence; eHTA, early Health Technology Assessment; HTA, Health Technology Assessment
Fig. 2
Fig. 2
Overview of the Radiology AI Deployment and Assessment Rubric (RADAR) framework, which could form a basis for early health technology assessment in radiology AI. The outer circle depicts the RADAR efficacy level, and the inner circle provides its description. AI, artificial intelligence. Reproduced from [35] Boverhof BJ et al (2024). Licensed under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/

Comment in

Similar articles

Cited by

References

    1. Zheng Q, Yang L, Zeng B et al (2021) Artificial intelligence performance in detecting tumor metastasis from medical radiology imaging: a systematic review and meta-analysis. EClinicalMedicine 31:100669. 10.1016/j.eclinm.2020.100669 - PMC - PubMed
    1. van Leeuwen KG, Schalekamp S, Rutten MJCM et al (2021) Artificial intelligence in radiology: 100 commercially available products and their scientific evidence. Eur Radiol 31:3797–3804. 10.1007/s00330-021-07892-z - PMC - PubMed
    1. Tariq A, Purkayastha S, Padmanaban GP et al (2020) Current clinical applications of artificial intelligence in radiology and their best supporting evidence. J Am Coll Radiol 17:1371–1381. 10.1016/j.jacr.2020.08.018 - PubMed
    1. Mehrizi MHR, Gerritsen SH, de Klerk WM et al (2022) How do providers of artificial intelligence (AI) solutions propose and legitimize the values of their solutions for supporting diagnostic radiology workflow? A technography study in 2021. Eur Radiol 33:915–924. 10.1007/s00330-022-09090-x - PMC - PubMed
    1. Farah L, Davaze-Schneider J, Martin T et al (2023) Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review. Artif Intell Med 140:102547. 10.1016/j.artmed.2023.102547 - PubMed

LinkOut - more resources